Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sykes Vet International is an Australian-based animal health company that develops, manufactures, and markets a diverse range of veterinary pharmaceuticals and nutritional supplements. The company's portfolio serves both the livestock industry—including cattle, sheep, and horses—and the companion animal market. Sykes is particularly renowned for its long-standing heritage in the Australian agricultural community, with its flagship Sykes's Drench being a staple for gastrointestinal health in livestock for over a century. In early 2023, the company was acquired by Virbac, a global leader in animal health, to strengthen Virbac's position in the Australian ruminant and equine segments. The company continues to operate as a key brand within the Virbac Australia portfolio, maintaining its focus on high-quality manufacturing and specialized veterinary solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sykes Vet International.